1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
